MICHAEL KILLIAN: Open Payments
NPI 1851342026 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,409 in 123 payments from 23 companies in 2025. Trend: 2023 $2,201 · 2024 $1,874 · 2025 $2,409
Food & beverage: $2,399Education: $10
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 25 | $597 |
| Novo Nordisk Inc | 15 | $303 |
| AstraZeneca Pharmaceuticals LP | 14 | $241 |
| ViiV Healthcare Company | 7 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $148 |
| Phathom Pharmaceuticals, Inc. | 8 | $114 |
| Merck Sharp & Dohme LLC | 5 | $106 |
| Lilly USA, LLC | 5 | $95 |
| PFIZER INC. | 5 | $92 |
| TOLMAR, INC. | 4 | $74 |
Products named: TRINTELLIX, AIRSUPRA, VOQUEZNA, Biktarvy, MOUNJARO, Wegovy, APRETUDE, JATENZO.
Industry payments across TX — which companies pay providers there.
